Identifying Unmet Clinical Needs: A Practical Guide for Medical Device Innovators

The best medical device companies in the world share one pattern: they found a problem worth solving before they found a solution. That sounds obvious. In practice, most device ideas start the other way around: a technology looking for a clinical application, or a clinician's instinct about a solution before the underlying need has been rigorously examined.

Structured needs-finding does not guarantee a successful device. It eliminates a specific category of failure: devices that solve problems clinicians did not actually have, did not care enough about to change behavior for, or already solved adequately with existing tools.

This article covers the practical methods for finding unmet clinical needs: where to look, how to observe, who to talk to, and how to filter what you find into a need worth pursuing.

What Is a Clinical Need in the Medical Device Context?

A clinical need is not a request for a product. It is a gap between the current state of care and the desired state of care for a defined patient population. The gap can appear in many forms: a procedure that is more difficult than it needs to be, a complication that occurs at a higher rate than it should, a diagnosis that arrives too late, an outcome that is worse than it would be with a different tool or approach.

The Stanford Biodesign program defines a need as "a need is a problem worth solving" and structures it with three components: the population affected, the outcome desired, and the current barrier to achieving it (Yock, P.G. et al., Biodesign: The Process of Innovating Medical Technologies, Cambridge University Press, second edition, https://biodesign.stanford.edu/our-work/biodesign-process/identify/needs-finding-and-needs-screening.html). A well-written need statement reads like this: "A way to [achieve this outcome] for [this patient population] without [the current limitation]." It does not name a solution. It names a gap.

That distinction matters because a solution-first statement locks the team into one technical approach before they understand the full range of alternatives. A problem-first statement keeps options open.

Where Do Unmet Clinical Needs Come From?

Unmet needs exist in every clinical environment. The question is how to surface them systematically rather than stumbling onto them by chance. Three sources account for most of the high-quality needs found by structured programs.

Clinical observation. Watching real procedures in the actual clinical environment is the most direct method. Observations that reveal needs include: moments where the clinician improvises or uses a tool in a way it was not designed for, pauses in a procedure caused by a problem with a tool or a technique, verbal expressions of frustration, workarounds that add time or complexity, and complications that occur in a pattern. The observer's job is not to propose solutions on the spot. It is to document what is seen without editorial judgment.

Clinician and patient interviews. Structured conversations with surgeons, anesthesiologists, nurses, technicians, and patients complement observation by surfacing problems that do not occur on a typical observation day or that are not visible from the observer's position. Interview technique matters: questions that surface problems are open-ended and problem-focused ("Tell me about the most difficult part of this procedure" rather than "Would you use a device that did X?"). Solution-focused questions lead to solution answers rather than problem answers.

Clinical literature and complication data. Peer-reviewed publications, medical conference proceedings, adverse event reports in the FDA's MAUDE database (https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/search.cfm), and medical device recall databases reveal where existing solutions have failed or where complications occur at a persistent rate. These sources surface needs that have been documented but not yet solved commercially.

The Clinical Immersion Method

Clinical immersion, the practice of spending extended time in a clinical environment with the goal of observing needs rather than validating solutions, is the foundation of structured needs-finding programs including Stanford Biodesign and its derivatives at other institutions.

A practical immersion program for an early-stage team includes the following elements.

Environment selection. Choose one or more clinical settings where the target problem is likely to appear. For a surgical device, this means an OR. For a diagnostic device, this might mean a radiology suite, an emergency department, or a point-of-care clinic. The setting should be representative of the primary use environment, not a best-case showcase site.

Duration. Single-visit observation produces anecdotes. Pattern recognition requires repeated visits across different days, different clinicians, and different patient presentations. Biodesign programs typically prescribe weeks of immersion before need-statement generation begins.

Documentation. Every observation should be recorded immediately and in detail: what happened, when, what the clinician did, what the consequence was, and what the current workaround was (if any). Most teams use written field notes; some use audio or video with appropriate IRB and institutional approvals where required.

Breadth before depth. The early stages of immersion should generate a large quantity of raw observations before any filtering occurs. Teams that begin filtering too early tend to converge on the first interesting problem rather than the best problem. The Biodesign process commonly generates hundreds of raw need observations before screening begins.

Who to Talk To: Building a Clinical Advisory Panel

Observation reveals what happens in the clinical environment. Structured interviews reveal why it happens, how clinicians think about it, and what they have already tried. The people worth talking to span several stakeholder categories.

Physicians. Surgeons, interventionalists, specialists, and primary care physicians depending on the target setting. Prioritize physicians who perform high volumes of the relevant procedure, because their pattern recognition about problems is more refined than low-volume practitioners. Include academic and community practitioners: academic centers tend to see more complex or referral cases; community and ambulatory settings often carry a large share of routine volume.

Nurses and allied health professionals. Scrub nurses, surgical techs, perfusionists, and radiology technicians often have the most detailed day-to-day experience with the practical limitations of existing devices. Their perspective complements the physician's view and often surfaces problems the physician has stopped noticing.

Patients and caregivers. Patient experience reveals needs that clinical observation misses: the burden of recovery, adherence to a post-procedure protocol, quality of life during treatment, and the gap between clinical outcome measures and what patients actually care about. Patient advocacy organizations and patient registries are often useful access points.

Hospital administrators and value analysis committee members. These are the buyers. Their perspective on what a new device needs to cost, how it would need to be reimbursed, and whether the clinical benefit would clear their procurement threshold is a form of needs data. A device that solves the clinical problem but cannot pass the value analysis committee has a commercial need problem, not just a clinical one.

Needs Filtering: How to Narrow Hundreds of Observations to a Handful Worth Pursuing

A productive immersion generates more raw observations than any team can address. The filtering process evaluates each observed need against criteria that predict commercial viability.

Clinical significance. When this problem occurs, how bad is it? Does it affect the patient outcome, the procedure time, the complication rate, or the clinician's ability to do their job? Significant problems are worth solving. Minor inconveniences are not.

Frequency. How often does this problem occur? A problem that affects one in ten thousand procedures may be clinically significant but may not support a commercial device business unless the procedure volume is enormous or the device ASP is very high.

Current solution inadequacy. How well do existing tools and techniques address this problem? If clinicians have a good existing solution and are satisfied with it, the bar to displacement is high. If the current approach is a workaround that adds risk, time, or cost, the bar to adoption is lower.

Stakeholder alignment. Do clinicians, patients, administrators, and payers all agree that this is a problem worth solving? Alignment across stakeholders is a strong predictor of adoption. Misalignment is a predictor of commercial failure even when the clinical case is compelling.

Regulatory fit. Is the likely device to address this need one that would require a 510(k), De Novo, or PMA pathway? Needs that can be addressed with a 510(k)-eligible device reach the market faster and at lower capital cost than needs requiring PMA. This is a commercial filter, not a clinical one.

The Biodesign process uses a formal needs-screening tool that rates each need against multiple dimensions and produces a prioritized list. Teams working without that framework can replicate the structure informally by scoring each need on the five dimensions above and sorting by combined score.

Common Mistakes in Clinical Needs-Finding

Staying in a single clinical site. One institution's workarounds are not the same as the field's. A need that appears consistently across institutions is more likely to represent a genuine gap than a local adaptation.

Letting the solution emerge during observation. When an observer identifies a possible solution during the immersion phase, they tend to unconsciously seek evidence confirming the need that solution would address and discount evidence of other needs. Separating observation from ideation reduces this bias.

Treating physician enthusiasm as market validation. A physician who says "I'd use that" is expressing clinical interest, not purchase intent. The commercial test is different from the clinical test.

Ignoring the patient perspective. Clinical observation from the physician's side of the procedure does not reveal the patient's experience of the problem or the patient's priorities for what a solution should achieve. Patient-centered needs often differ from clinician-centered ones.

From Clinical Need to Marketing Positioning

The clinical need you identify in this phase becomes the foundation of every downstream marketing decision: the claim you make in your product labeling, the problem you describe in your sales materials, the outcome you demonstrate in your clinical evidence program, and the positioning you build against competitors.

Buzzbox Media works with medtech companies to translate clinical evidence and validated needs into go-to-market strategy and FDA-compliant marketing programs. Companies that start this conversation at the validation stage arrive at launch with more defensible positioning than those who engage a marketing team for the first time six months before launch. If you want to talk through how clinical needs-finding connects to your marketing and positioning program, book a 30-minute call at https://www.buzzboxmedia.com/book.